Ecraid attends AMR Conference 2025 in Basel
Come meet our team at Ecraid's exhibition booth at AMR Conference 2025 next month. We are part of the scientific programme, too. Hear Ecraid CEO Marc Bonten speak on the importance of clinical endpoints for ensuring high-quality research outcomes.
Ecraid is pleased to participate in the 9th AMR Conference, taking place on 25–26 February 2025 at the Basel Congress Centre, Switzerland. Organised by BEAM Alliance (Biotech companies in Europe combating AntiMicrobial Resistance) and bamconn GmbH, this annual conference brings together over 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative solutions against antibiotic-resistant pathogens.
Visit the Ecraid booth
Will you be attending? Come by the Ecraid booth to learn more about our ‘warm-base’ clinical research networks, our ongoing studies, and how we can support and accelerate your clinical research projects.
Times: Tuesday, 25 February, 10:00 – 21:30 CET (reception from 19:30); Wednesday, 26 February, 08:30 – 18:00 CET
Venue: Exhibition booth 14 on the 2nd floor of Congress Centre Basel
Don’t miss
Two of our affiliated experts are contributing to the event's scientific programme. Ecraid CEO Marc Bonten and Ecraid Coordinating Committee member Sibyl Anthierens will be joining parallel sessions on pressing issues affecting AMR research.
Clinical endpoints: fit-for-purpose?
Ecraid CEO Marc Bonten will be speaking on the importance of clinical endpoints in ensuring high-quality research outcomes.
Date: 26 February 2025
Time: 10:00 – 11:00
Venue: Room Sydney, 2nd floor, Basel Congress Centre
Speakers: Marc Bonten (Ecraid), Radu Botgros (European Medicines Agency), Peter Kim (U.S. Food & Drug Administration)
Moderator: Rienk Pypstra (tranScrip)
Challenges in diagnostic uptakes
Ecraid Coordinating Committee member Sibyl Anthierens will discuss challenges in diagnostic uptakes. She explains:
“I look forward to sharing insights from our implementation and social science work on enhancing the uptake of diagnostics to tackle AMR. By integrating these lessons learned, we can drive more effective adoption, support evidence-based decision-making, and create sustainable impact in antimicrobial stewardship.”
Date: 26 February 2025
Time: 10:00 – 11:00
Venue: Room Singapore, 2nd floor, Basel Congress Centre
Speakers: Sibyl Anthierens (University of Antwerp), Alexander Krause (bioMérieux), Akhil Bansal (AMR Funding Circle), Holger Rohde (Hamburg University Hospital)
Moderator: Robert Leo Skov (ESCMID)
The full programme is now live on the AMR Conference website.